Mark L. Tykocinski, MD
Mark L. Tykocinski, MD, Provost, Thomas Jefferson University; Dean, Sidney Kimmel Medical College at TJU
Dr. Tykocinski serves as Provost and Executive Vice President for Academic Affairs, Thomas Jefferson University, and the Anthony F. and Gertrude M. DePalma Dean of Sidney Kimmel Medical College at Thomas Jefferson University. For over five years, he also served as President of Jefferson University Physicians. Before joining Jefferson in 2008, he was Professor and Chair of the Department of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine for a decade. Dr. Tykocinski’s research contributions have been in the fields of molecular and cellular immunology, for which he holds a series of research patents. He serves as SAB Chair for KAHR-Medical, the Israeli biotech company he founded in 2007 for fusion protein technologies. He is Past President of the Association of Pathology Chairs and the American Society for Investigative Pathology/FASEB. He has been on the editorial boards of the American Journal of Pathology, Molecular Oncology and Genetics Research, and was honored with the Warner-Lambert/Parke-Davis Award for Outstanding Research from the American Society for Investigative Pathology/Federation of American Societies for Experimental Biology. He is a member of the Board of Directors at Christiana Care Health System. He also is on the Board of Trustees for the Philadelphia County Medical Society. He earned a B.A. in biology magna cum laude from Yale University and his M.D. from New York University.